Jump to section
To help millions of people live healthier lives by being the missing, caring link between those who make medicines, treatments, and diagnostics, and those who take them.
Hoping to make healthcare work better for more people, Ostro provides an engagement platform to connect healthcare brands and their treatments and devices to consumers and healthcare provider (HCPs).
For consumers and HCPs, Ostro supplies its "Navigate" tool, that enables them to access information about treatment and support options on the market, and ultimately find the right product to purchase or invest in. If a person requires a deeper experience, Ostro Consult connects them to an experienced clinician to answer their specific questions via a HIPAA-compliant video or chat experience.
For healthcare brands, Ostro's "Attribute" product can be used to gather powerful engagement metrics and insights, to inform decision making and optimize marketing spend. All these tools combine to make Ostro a great option for brands, HCPs, and consumers alike. With significant funding at its back, it will be certainly be interesting to see what direction the company takes next.
Freddie
Company Specialist at Welcome to the Jungle
Nov 2022
$45m
EARLY VC
Aug 2021
$23.1m
SERIES A
This company has top investors
Ahmed Elsayyad
(President)Investor at Caffeinated Capital Collective, and Adjunct Instructor at New York University. Worked for a short time as a Bioethics Researcher at the Johns Hopkins Bloomberg School of Public Health.
Chase Feiger, MD
(CEO)Contributing Writer for Forbes, Scout for Sequoia Capital, and Adjunct Lecturer at New York University. Previously co-founded Parsable, an enterprise SaaS company.
Ryan Junee
(Board Member)CEO at Quintessential Ventures, Managing Partner at Electric Ant, Co-founder and Board Member at GoodCash, and Co-founder and Board Member at Parsable.